Skip to content
Recall Observatory FDA recall evidence

Device product

URO-3 Triple Stain (CD44 + p53) with CK20, Catalog #: PM370TSAA, Package Type: Bag, which contains components: a) CD44 + p53, Catalog #: PM373DSAA, Package Type: Bottle, and b) CK20, Catalog #: PM062AA, Package Type: Bottle Product Usage: URO-3 Triple Stain (CD44 + p53) with CK20 is a cocktail of mouse monoclonal and rabbit monoclonal antibodies that is intended for laboratory use in the qualitative identification of CD44, p53 and CK20 proteins by immunohistochemistry (IHC) in formalin-fixed paraffin-embedded (FFPE) human tissues, primarily for bladder cancer characterization. The clinical interpretation of any staining or its absence should be complemented by morphological studies using proper controls and should be evaluated within the context of the patient s clinical history and other diagnostic tests by a qualified pathologist. The URO-3 Triple Stain is an adjunct immunohistochemistry test to assist a qualified pathologist in differentiating urothelial reactive atypia from CIS (carcinoma in situ) in suspected bladder lesions. The URO-3 staining pattern will be used as supporting data along with morphological and patient history context for the qualified pathologist to render a diagnosis.

Z-3198-2018

March 15, 2018

Class II

Product summary

Firm
Biocare Medical, LLC
Event
Event 80407
Status
Terminated
Classification
Class II
Quantity
11
Official record key
device-enforcement:Z-3198-2018

Official wording

Reason: Immunohistochemistry device kits found to display incorrect staining pattern due to mislabeling of two components.

Code information: Lot: 060617, Expiration: 2019/05 with a) Lot: 060117, and b) 053117

Distribution pattern: Worldwide Distribution - Unites States Nationwide in the states of NY AND FL and the countries of: Morocco and Italy

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    mislabeling